Form 10-Q · Quarterly report
Verisign 10-Q, filed Jul 23, 2026
- Filed
- CIK
- 0001014473
- Accession no.
- 0001014473-26-000028
Summary
Verisign reported second-quarter 2026 revenue of $434.6 million, up 6% year over year, and 179.1 million .com and .net registrations as of June 30, 2026. The company also said it will raise the .com wholesale registration fee to $10.97 effective November 1, 2026, and announced that the .web top-level domain was delegated into the DNS root zone with Verisign as the designated registry operator.
Key points
- Verisign said it will increase the annual .com wholesale registration fee from $10.26 to $10.97 effective November 1, 2026.
- Verisign's board authorized an additional $884.2 million for share repurchases on July 23, 2026, bringing total authorization under the program to $1.50 billion.
- The board declared a quarterly cash dividend of $0.81 per share, payable August 27, 2026 to stockholders of record on August 19, 2026.
- Verisign processed 12.7 million new .com and .net registrations in Q2 2026, up from 10.4 million a year earlier, and the final Q1 2026 renewal rate was 76.3%.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION Overview We are a global provider of critical internet infrastructure and domain name registry services, enabling internet navigation for many of the world’s most recognized domain names. We help enable the security, stability, and resiliency of the Domain Name System (“DNS”) and the internet by providing Root Zone Maintainer Services, operating two of the thirteen global internet root servers, and providing registration services and authoritative resolution for the .com and .net generic top-level domains (“gTLDs”), which support the majority of global e-commerce. As of June 30, 2026, we had 179.1 million .com and .net registrations in the domain name base. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.